Bill Grubb, Vice President, Business Development and Innovation, oversees all aspects of Noramco’s strategic growth and innovation functions, including acquisitions, partnerships, and new product development platforms. Bill is integral to advancing and diversifying the portfolio of products, developing fast-track processes to move upstream R&D through stage gates, to FDA filings, and to the supply chain. As part of his responsibilities, Bill also leads the strategic planning, pricing, marketing & external communications functions for Noramco. Joining Noramco in 1997, he brings a unique perspective to the role, having spent equal time in development, operations, and commercial leadership positions. Bill led the global team that developed, filed, and launched 10 of the products that make-up the core Noramco product line today, and before his current role, led the global commercial team. Bill has a 25+ year proven track record of success in the branded drug and generic API industry, working for Burroughs-Welcome, Glaxo, and Johnson & Johnson. Bill holds a degree in Chemistry and Physics and a strategic management certificate from Northwestern’s Kellogg School of Management.